12/23/2021Pfizer Gains Chinese Approval of ADC Drug Besponsa

12/21/2021CDE Seeks Comments on Draft Chinese Translation of ICH Guideline ICH M...

12/21/2021CStone announced New Drug Approval of Cejemly® (Sugemalimab) in China

12/21/2021Pfizer Wins Chinese BLA Approval of Inotuzumab Ozogamicin for BCP-ALL

12/20/2021NHSA Issues the List of DRG/DIP Reform Demo Trial Sites

12/20/2021NHC Issues the Guidelines for Building and Management of Pharmacy Intr...

12/20/2021Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...

12/20/2021MOF: China To Lower Import Tariffs on 954 Products in 2022

12/20/2021Novartis Granted Chinese Approval of Its Anti-CD20 Antibody Ofatumumab...

12/20/2021Xpovio Combo Conditionally Approved in China for Repeatedly Treated rr...

12/20/2021Cytokinetics and Ji Xing Expand Collaboration for Omecamtiv Mecarbil i...

12/17/2021CBMG Cleared of U.S. IND of Bi-Specific CAR-T Cell Therapy C-CAR039...

12/17/2021BioMarin and Skyline Therapeutics in Deal to Co-develop Novel Gene The...

12/17/2021IQVIA: Chinese Retail Pharmacy Sales Up Only 0.3% in Q3/2021

12/17/2021Review of Retail Pharmacy Sales of VBP Prevailing and Failure Drug Pro...

12/17/2021Recent Executive Moves

12/16/2021US Sanctions Chinese Painkiller Makers Amid Addiction Epidemic, As Sen...

12/16/2021Zai Lab's NUZYRA Approved in China as a Class 1 New Drug for CABP and ...

12/16/2021US Sanctions Chinese Tech Firms/Institutes for Weaponizing Biotech, Sp...

12/15/2021China Biopharma, Tech Stocks Fall on Reports of Expanded U.S. Sanction...

12/15/2021New Study: China Healthcare under Remaking in Digital Era

12/15/2021Chinese Telemedicine Stocks Feel the Pain as Tougher Rules Loom (WSJ)

12/14/2021Antengene Enters Clinical Collaboration with BMS to Evaluate ATG-017 i...

12/14/2021China Issues the Provisions for National Pharmaceutical Reserve (2021 ...

12/13/2021IQVIA: Chinese Hospital Drug Market Growth Slowed to 2.7% in Q3/2021

12/13/2021Universe and Kitanihon Enter Strategic Deal with Plan for Kampo Man...

12/13/2021Biosion Licenses Worldwide Rights of Anti-TROP-2 mAb BSI04702 to OBI P...

12/13/2021CDE: Annual Report on Clinical Trials for New Drug Registration in Chi...

12/13/2021China's NRDL Explained: 67 New Drugs, 62% Price Cut, 80% Success Rate ...

12/13/2021Nine Observations from A Busy Few Weeks Back at the Heart of the China...

Page:85/367 Total number of articles:10986: [First][<<] [83] [84] [85] [86] [87] [>>] [End]